Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue November 2014
 •  Hair Today, Gone Tomorrow  •  President Signs Sunscreen Innovation Act  •  Rob Lowe, The Formulator  •  Body Shop Donating To War Child  •  L’Oréal To Honor Social Responsibility in Dermatology
Print

Fuji Chemical Granted Inflammation Patent



Published September 8, 2006
Related Searches: eye patent ink industry
Post a comment
Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.



blog comments powered by Disqus